tm logo
Trademark Search
TYFARGIS

View On IC.GC.CA

TYFARGIS
REGISTERED

on 17 Sep 2024

Last Applicant/ Owned by

SEAGEN INC.

21823 30th Drive S.E.Bothell, WA 98021

US

Serial Number

1961728 filed on 08th May 2019

Registration Number

TMA1257183 registered on 17th Sep 2024

Registration expiry Date

17th Sep 2034

Correspondent Address

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

TYFARGIS

Trademark usage description

pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of nervous system diseases, for the Read More

Classification Information

Class [005]
Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of nervous system diseases, for the regulation of the immune system and for treatment of auto-immune diseases, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of cancer, and inflammatory disorders, for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology; pharmaceutical preparations for the prevention and treatment of nervous system diseases, for the regulation of the immune system and for treatment of auto-immune diseases, the cardio-vascular system, metabolic diseases, the respiratory system, the musculo-skeletal system, and the genitourinary system namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory muscle diseases and disorders; pharmaceutical preparations for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology

Classification kind code

11

Class [042]
Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation

Classification kind code

11

Mark Details

Serial Number

1961728

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 27
on 26th Feb 2024		Approval Notice Sent
Submitted for opposition 26
on 26th Feb 2024		Approved
Submitted for opposition 67
on 29th Sep 2023		Agent Name Changed
Submitted for opposition 22
on 10th Mar 2023		Search Recorded
Submitted for opposition 20
on 10th Mar 2023		Examiner's First Report
Submitted for opposition 287
on 30th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 135
on 03rd May 2021		Amendment to Application
Submitted for opposition 31
on 10th May 2019		Formalized
Submitted for opposition 1
on 09th May 2019		Created
Submitted for opposition 30
on 08th May 2019		Filed